These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 8901839

  • 21. Association of transforming growth factor-beta1 gene polymorphisms with myocardial infarction in patients with angiographically proven coronary heart disease.
    Koch W, Hoppmann P, Mueller JC, Schömig A, Kastrati A.
    Arterioscler Thromb Vasc Biol; 2006 May; 26(5):1114-9. PubMed ID: 16543493
    [Abstract] [Full Text] [Related]

  • 22. Transforming growth factor-beta1 gene polymorphisms and coronary artery disease.
    Syrris P, Carter ND, Metcalfe JC, Kemp PR, Grainger DJ, Kaski JC, Crossman DC, Francis SE, Gunn J, Jeffery S, Heathcote K.
    Clin Sci (Lond); 1998 Dec; 95(6):659-67. PubMed ID: 9831690
    [Abstract] [Full Text] [Related]

  • 23. Neutrophil elastase gene variation and coronary heart disease.
    Schönfelder J, Telgmann R, Nicaud V, Brand E, Dördelmann C, Rüssmann C, Beining K, Schmidt-Petersen K, Evans A, Kee F, Morrison C, Arveiler D, Cambien F, Paul M, Brand-Herrmann SM.
    Pharmacogenet Genomics; 2007 Aug; 17(8):629-37. PubMed ID: 17622939
    [Abstract] [Full Text] [Related]

  • 24. The transforming growth factor-beta1 codon 10 gene polymorphism and accelerated graft vascular disease after clinical heart transplantation.
    Holweg CT, Baan CC, Balk AH, Niesters HG, Maat AP, Mulder PM, Weimar W.
    Transplantation; 2001 May 27; 71(10):1463-7. PubMed ID: 11391236
    [Abstract] [Full Text] [Related]

  • 25. Polymorphisms and haplotype structures in genes for transforming growth factor beta1 and its receptors in familial and unselected breast cancers.
    Jin Q, Hemminki K, Grzybowska E, Klaes R, Söderberg M, Zientek H, Rogozinska-Szczepka J, Utracka-Hutka B, Pamula J, Pekala W, Försti A.
    Int J Cancer; 2004 Oct 20; 112(1):94-9. PubMed ID: 15305380
    [Abstract] [Full Text] [Related]

  • 26. The Gln/Arg polymorphism of human paraoxonase (PON 192) is not related to myocardial infarction in the ECTIM Study.
    Herrmann SM, Blanc H, Poirier O, Arveiler D, Luc G, Evans A, Marques-Vidal P, Bard JM, Cambien F.
    Atherosclerosis; 1996 Oct 25; 126(2):299-303. PubMed ID: 8902155
    [Abstract] [Full Text] [Related]

  • 27. Medical treatment of myocardial infarction in France and Northern Ireland. Results from the ECTIM study. Enquête cas-Témoins de l'Infarctus du Myocarde.
    Marques-Vidal P, Cambou JP, Evans A, Arveiler D, Luc G, Bingham A, Cambien F.
    Eur Heart J; 1995 Mar 25; 16(3):348-53. PubMed ID: 7789377
    [Abstract] [Full Text] [Related]

  • 28. Familial defective apolipoprotein B-100 and myocardial infarction. The ECTIM study. Etude Cas-Témoins de l'Infarctus du Myocarde.
    Brousseau T, Arveiler D, Cambou JP, Evans AE, Luc G, Fruchart JC, Cambien F, Amouyel P.
    Atherosclerosis; 1995 Aug 25; 116(2):269-71. PubMed ID: 7575782
    [No Abstract] [Full Text] [Related]

  • 29. Specific haplotypes of the P-selectin gene are associated with myocardial infarction.
    Tregouet DA, Barbaux S, Escolano S, Tahri N, Golmard JL, Tiret L, Cambien F.
    Hum Mol Genet; 2002 Aug 15; 11(17):2015-23. PubMed ID: 12165563
    [Abstract] [Full Text] [Related]

  • 30. Polymorphisms of the tumour necrosis factor-alpha gene, coronary heart disease and obesity.
    Herrmann SM, Ricard S, Nicaud V, Mallet C, Arveiler D, Evans A, Ruidavets JB, Luc G, Bara L, Parra HJ, Poirier O, Cambien F.
    Eur J Clin Invest; 1998 Jan 15; 28(1):59-66. PubMed ID: 9502188
    [Abstract] [Full Text] [Related]

  • 31. Genetic variation at the angiotensinogen locus in relation to high blood pressure and myocardial infarction: the ECTIM Study.
    Tiret L, Ricard S, Poirier O, Arveiler D, Cambou JP, Luc G, Evans A, Nicaud V, Cambien F.
    J Hypertens; 1995 Mar 15; 13(3):311-7. PubMed ID: 7622852
    [Abstract] [Full Text] [Related]

  • 32. TGF-beta 1 polymorphisms and risk of myocardial infarction and stroke: the Rotterdam Study.
    Sie MP, Uitterlinden AG, Bos MJ, Arp PP, Breteler MM, Koudstaal PJ, Pols HA, Hofman A, van Duijn CM, Witteman JC.
    Stroke; 2006 Nov 15; 37(11):2667-71. PubMed ID: 17023672
    [Abstract] [Full Text] [Related]

  • 33. The 4G/5G genetic polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene is associated with differences in plasma PAI-1 activity but not with risk of myocardial infarction in the ECTIM study. Etude CasTemoins de I'nfarctus du Mycocarde.
    Ye S, Green FR, Scarabin PY, Nicaud V, Bara L, Dawson SJ, Humphries SE, Evans A, Luc G, Cambou JP.
    Thromb Haemost; 1995 Sep 15; 74(3):837-41. PubMed ID: 8571307
    [Abstract] [Full Text] [Related]

  • 34. Apolipoprotein B signal peptide polymorphism in patients with myocardial infarction and controls. "The ECTIM study".
    Visvikis S, Cambou JP, Arveiler D, Evans AE, Parra HJ, Aguillon D, Fruchart JC, Siest G, Cambien F.
    Hum Genet; 1993 Jan 15; 90(5):561-5. PubMed ID: 8428755
    [Abstract] [Full Text] [Related]

  • 35. Association of transforming growth factor-β1 gene polymorphisms with genetic susceptibility to acute myocardial infarction.
    Najar RA, Ghaderian SM, Panah AS.
    Am J Med Sci; 2011 Nov 15; 342(5):365-70. PubMed ID: 21685787
    [Abstract] [Full Text] [Related]

  • 36. Association of a polymorphism of the transforming growth factor-beta1 gene with blood pressure in Japanese individuals.
    Yamada Y, Fujisawa M, Ando F, Niino N, Tanaka M, Shimokata H.
    J Hum Genet; 2002 Nov 15; 47(5):243-8. PubMed ID: 12032592
    [Abstract] [Full Text] [Related]

  • 37. The P-selectin gene is highly polymorphic: reduced frequency of the Pro715 allele carriers in patients with myocardial infarction.
    Herrmann SM, Ricard S, Nicaud V, Mallet C, Evans A, Ruidavets JB, Arveiler D, Luc G, Cambien F.
    Hum Mol Genet; 1998 Aug 15; 7(8):1277-84. PubMed ID: 9668170
    [Abstract] [Full Text] [Related]

  • 38. Association between transforming growth factor beta1 gene polymorphisms and IgA nephropathy.
    Carturan S, Roccatello D, Menegatti E, Di Simone D, Davit A, Piazza A, Sena LM, Matullo G.
    J Nephrol; 2004 Aug 15; 17(6):786-93. PubMed ID: 15593052
    [Abstract] [Full Text] [Related]

  • 39. [Genetic factors in myocardial infarction--Results from a candidate gene and a genome-wide approach between beta blockers].
    Hengstenberg C, Bröckel U, Holmer S, Mayer B, Fischer M, Baessler A, Erdmann J, Lieb W, Löwel H, Riegger G, Schunkert H.
    Herz; 2002 Nov 15; 27(7):649-61. PubMed ID: 12439636
    [Abstract] [Full Text] [Related]

  • 40. Sequence polymorphisms in the apolipoprotein(a) gene and their association with lipoprotein(a) levels and myocardial infarction. The ECTIM Study.
    Brazier L, Tiret L, Luc G, Arveiler D, Ruidavets JB, Evans A, Chapman J, Cambien F, Thillet J.
    Atherosclerosis; 1999 Jun 15; 144(2):323-33. PubMed ID: 10407493
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.